Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +42.18%
#2 0G 0G +27.29%
#3 Pons Pons +26.97%
#4 SAFEcoin SAFEcoin +26.87%
#5 Zora Zora +25.96%
#6 Seeker Seeker +23.15%
#7 VVS Finance VVS Finance +21.62%
#8 Full Moon Full Moon +17.50%
#9 ADO Protocol ADO Protocol +16.58%
#10 Apertum Apertum +15.82%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Graphite Bio, Inc. Graphite Bio, Inc.

Graphite Bio, Inc.

GRPH
Rang în acțiuni #12751
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
Preț acțiune
$22.26
Ultima sincronizare: 2024-03-22
Capitalizare de piață
$553.40M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Graphite Bio, Inc. (GRPH)

Categorie

Healthcare
Venituri pentru Graphite Bio, Inc. (GRPH)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale Graphite Bio, Inc., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Graphite Bio, Inc. din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH